Loading company…
Riskpilot
← Back to search
Sign in
Get full access
DrugWise Discovery ApS
APS
Active
CVR 43888862
Nordre Fasanvej 215, 1.
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2023
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 135K
-53% vs 2023
EBITDA margin
100.0%
-53% vs 2023
Equity ratio
65.2%
Financial strength
Net profit 2024
DKK 105K
-53% vs 2023
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK 135K
-53%
EBITDA
DKK 135K
-53%
Net profit
DKK 105K
-53%
Total assets
DKK 563K
+55%
Equity
DKK 367K
+39%
Employees
—
—
Company information
Legal name
DrugWise Discovery ApS
CVR number
43888862
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
16. februar 2023
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive konsulent virksomhed indenfor biotech samt enhver virksomhed i hermed stående forbindelse.
Contact
Address
Nordre Fasanvej 215, 1.
Phone
+4530603430
Email
harris@b4ceramics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
287
135
Staff expenses
-0
-0
EBITDA
287
135
Depreciation & amort.
-0
-0
EBIT
287
135
Net financials
-1
-1
Profit before tax
286
134
Tax
63
30
Net profit
223
105
Balance sheet
DKK thousands
Item
2023
2024
Total assets
362
563
Equity
263
367
Long-term debt
0
0
Short-term debt
99
196
Total debt
99
196
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2023
2024
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
2023
2024
Return on equity
28.6%
This company
18.4%
Market median
+55% vs market
2023
2024
Net profit margin
77.5%
This company
8.1%
Market median
+857% vs market
2023
2024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
2023
2024
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-02-16 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SJ
Samra Joke Sanni
Management
Management
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NSSK Holding ApS
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
NSSK Holding ApS
DrugWise Discovery ApS
(this company)
Board network connections
Board members of DrugWise Discovery ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Samra Joke Sanni
Management
0 companies